JP2005509590A5 - - Google Patents

Download PDF

Info

Publication number
JP2005509590A5
JP2005509590A5 JP2003503584A JP2003503584A JP2005509590A5 JP 2005509590 A5 JP2005509590 A5 JP 2005509590A5 JP 2003503584 A JP2003503584 A JP 2003503584A JP 2003503584 A JP2003503584 A JP 2003503584A JP 2005509590 A5 JP2005509590 A5 JP 2005509590A5
Authority
JP
Japan
Prior art keywords
phenyl
methoxy
phenoxy
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003503584A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005509590A (ja
JP2005509590A6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/016950 external-priority patent/WO2002100813A2/en
Publication of JP2005509590A publication Critical patent/JP2005509590A/ja
Publication of JP2005509590A6 publication Critical patent/JP2005509590A6/ja
Publication of JP2005509590A5 publication Critical patent/JP2005509590A5/ja
Pending legal-status Critical Current

Links

JP2003503584A 2001-06-07 2002-05-30 ペルオキシソーム増殖因子活性化受容体の調節物質 Pending JP2005509590A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29714401P 2001-06-07 2001-06-07
US60/297,144 2001-06-07
PCT/US2002/016950 WO2002100813A2 (en) 2001-06-07 2002-05-30 Modulators of peroxisome proliferator activated receptors

Publications (3)

Publication Number Publication Date
JP2005509590A JP2005509590A (ja) 2005-04-14
JP2005509590A6 JP2005509590A6 (ja) 2005-08-04
JP2005509590A5 true JP2005509590A5 (enExample) 2006-01-05

Family

ID=23145037

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003503584A Pending JP2005509590A (ja) 2001-06-07 2002-05-30 ペルオキシソーム増殖因子活性化受容体の調節物質

Country Status (24)

Country Link
US (2) US7192982B2 (enExample)
EP (1) EP1392637A2 (enExample)
JP (1) JP2005509590A (enExample)
KR (1) KR20040012905A (enExample)
CN (1) CN1543451A (enExample)
AR (1) AR036084A1 (enExample)
BR (1) BR0210190A (enExample)
CA (1) CA2449256A1 (enExample)
CO (1) CO5640097A2 (enExample)
CZ (1) CZ20033309A3 (enExample)
EA (1) EA200400010A1 (enExample)
EC (1) ECSP034877A (enExample)
EE (1) EE200400001A (enExample)
HR (1) HRP20031001A2 (enExample)
HU (1) HUP0400280A3 (enExample)
IL (1) IL158873A0 (enExample)
MX (1) MXPA03011201A (enExample)
NO (1) NO20035439D0 (enExample)
NZ (1) NZ529351A (enExample)
PE (1) PE20030099A1 (enExample)
PL (1) PL368051A1 (enExample)
SK (1) SK14912003A3 (enExample)
WO (1) WO2002100813A2 (enExample)
ZA (1) ZA200308863B (enExample)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ529351A (en) * 2001-06-07 2006-01-27 Lilly Co Eli Modulators of peroxisome proliferator activated receptors
EA200400011A1 (ru) 2001-06-07 2004-06-24 Эли Лилли Энд Компани Модуляторы рецепторов, активируемых пролифераторами пероксисом (prar)
KR100965201B1 (ko) * 2001-06-12 2010-06-24 웰스테트 테라퓨틱스 코포레이션 대사 질환의 치료용 화합물
ITRM20020016A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
PL376736A1 (pl) * 2002-11-25 2006-01-09 Galderma Research & Development, S.N.C. Nowe związki diaromatyczne, które aktywują receptor typu PPAR<$Egamma> i ich zastosowanie w kompozycjach kosmetycznych lub farmaceutycznych
FR2847580B1 (fr) * 2002-11-25 2006-03-03 Galderma Res & Dev NOUVEAUX COMPOSES BI-AROMATIQUES ACTIVATEURS DES RECEPTEURS DE TYPE PPARy ET LEUR UTILISATION DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
US7192970B2 (en) * 2002-11-26 2007-03-20 Chipscreen Biosciences, Ltd. Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
CA2512883A1 (en) 2003-02-14 2004-09-02 Eli Lilly And Company Sulfonamide derivatives as ppar modulators
GB0314075D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
WO2005009104A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
WO2005019151A1 (en) * 2003-08-20 2005-03-03 Eli Lilly And Company Ppar modulators
EP2100877B1 (en) 2003-09-19 2012-01-25 Janssen Pharmaceutica N.V. 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JP2007508382A (ja) * 2003-10-14 2007-04-05 イーライ リリー アンド カンパニー Ｐｐａｒモジュレータとしてのフェノキシエーテル誘導体
CA2551610A1 (en) 2003-12-25 2005-07-14 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl)propanoic acid derivatives
JP4074616B2 (ja) * 2003-12-25 2008-04-09 武田薬品工業株式会社 ３−（４−ベンジルオキシフェニル）プロパン酸誘導体
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
ATE453617T1 (de) * 2004-05-12 2010-01-15 Proteotech Inc Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
US7622491B2 (en) * 2004-08-13 2009-11-24 Metabolex Inc. Modulators of PPAR and methods of their preparation
US7405236B2 (en) * 2004-08-16 2008-07-29 Hoffman-La Roche Inc. Indole derivatives comprising an acetylene group
CN101014332A (zh) * 2004-09-13 2007-08-08 参天制药株式会社 角膜结膜病变治疗剂
MY145712A (en) * 2004-09-15 2012-03-30 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MY147518A (en) * 2004-09-15 2012-12-31 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
US7635779B2 (en) * 2004-10-15 2009-12-22 Council Of Scientific & Industrial Research Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents
FR2882359A1 (fr) * 2005-02-24 2006-08-25 Negma Lerads Soc Par Actions S Derives activateurs de ppar, procede de preparation et application en therapeutique
JO3006B1 (ar) * 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
MX2008012506A (es) * 2006-03-31 2008-10-14 Wellstat Therapeutics Corp Tratamiento de combinacion de trastornos metabolicos.
UY30288A1 (es) 2006-04-18 2007-08-31 Janssen Pharmaceutica Nv Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol
UA100497C2 (ru) 2006-09-07 2013-01-10 Никомед Гмбх Комбинированное лечение сахарного диабета
CN102114076B (zh) * 2006-10-25 2013-04-10 中国科学院上海生命科学研究院 肉桂提取物的制备方法、肉桂提取物、其组合物以及用途
KR101560844B1 (ko) 2007-06-04 2015-10-15 벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 트라이-아릴계 화합물 및 이를 포함하는 조성물
JP5496913B2 (ja) * 2008-01-15 2014-05-21 ウェルスタット セラピューティクス コーポレイション 代謝異常の治療のための化合物
US20090238900A1 (en) * 2008-03-24 2009-09-24 Himalaya Global Holdings Limited Novel anti-diabetic herbal composition, method for preparing the same and use thereof
JP5436941B2 (ja) * 2009-06-03 2014-03-05 あすか製薬株式会社 ラクタム化合物又はその塩及びｐｐａｒ活性化剤
RU2627703C2 (ru) * 2010-07-23 2017-08-10 Конекшис Лайф Сайенсиз Пвт. Лтд. Агонисты gpr40
WO2014130608A1 (en) * 2013-02-22 2014-08-28 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
EA201690938A1 (ru) 2013-11-05 2016-11-30 Бен-Гурион Юниверсити Оф Дзе Негев Рисерч Энд Дивелопмент Оторити Соединения для лечения диабета и осложнений, возникающих из-за этого заболевания
CN104987314A (zh) * 2015-07-14 2015-10-21 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途
CN104926746A (zh) * 2015-07-14 2015-09-23 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端胺基苄基类结构的化合物及其用途
CN104961703A (zh) * 2015-07-14 2015-10-07 佛山市赛维斯医药科技有限公司 一类苯并异恶唑类11β-HSD1抑制剂、制备方法及其用途
CN104961702A (zh) * 2015-07-14 2015-10-07 佛山市赛维斯医药科技有限公司 苯并异恶唑类11β-HSD1抑制剂、制备方法及其用途
CN105001174A (zh) * 2015-07-14 2015-10-28 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途
CN104926744A (zh) * 2015-07-14 2015-09-23 佛山市赛维斯医药科技有限公司 一类含苯并异恶唑和末端苄基类结构的化合物及其用途
CN104974103A (zh) * 2015-07-14 2015-10-14 佛山市赛维斯医药科技有限公司 一类含苯并异恶唑和烷氧苯基类结构的化合物及其用途
CN104926743A (zh) * 2015-07-14 2015-09-23 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端苄基类结构的化合物及其用途
CN104926745A (zh) * 2015-07-14 2015-09-23 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端卤代苄基类结构的化合物及其用途
CN104926742A (zh) * 2015-07-14 2015-09-23 佛山市赛维斯医药科技有限公司 一类含苯并异恶唑和硝基苯基类结构的化合物及其用途
CN104945344A (zh) * 2015-07-14 2015-09-30 佛山市赛维斯医药科技有限公司 一类含苯并异恶唑和末端胺基结构化合物及其用途
CN105037290A (zh) * 2015-07-14 2015-11-11 佛山市赛维斯医药科技有限公司 一类含苯并异恶唑和腈基苯类结构化合物及其用途
SG11202002032SA (en) 2017-09-22 2020-04-29 Jubilant Epipad LLC Heterocyclic compounds as pad inhibitors
CA3076476A1 (en) 2017-10-18 2019-04-25 Jubilant Epipad LLC Imidazo-pyridine compounds as pad inhibitors
BR112020008851A2 (pt) 2017-11-06 2020-10-20 Jubilant Prodel LLC composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas
PL3704120T3 (pl) 2017-11-24 2024-09-16 Jubilant Episcribe Llc Związki heterocykliczne jako inhibitory prmt5
SG11202008950PA (en) 2018-03-13 2020-10-29 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof
AU2024360314A1 (en) * 2023-10-13 2026-05-07 National Center Of Neurology And Psychiatry Neuroprotective agent

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
US5232945A (en) * 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
US5387672A (en) * 1993-03-02 1995-02-07 The University Of Maryland At Baltimore Hemoglobin intramolecularly cross-linked withlong chain divalent reagents
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
JP3964478B2 (ja) * 1995-06-30 2007-08-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
DE69815008T2 (de) 1997-09-19 2004-04-01 Ssp Co., Ltd. Alfa-substituierte Phenylpropionsäurederivate und diese enthaltende Arzneimittel
AU749505B2 (en) * 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
JP4345230B2 (ja) 1998-03-10 2009-10-14 小野薬品工業株式会社 カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
DK1206457T3 (da) * 1999-08-27 2004-02-16 Lilly Co Eli Biaryl-oxa(thia)zolderivater og deres anvendelse som modulatorer PPAP'ER
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
WO2001079150A1 (en) * 2000-04-17 2001-10-25 Novo Nordisk A/S New compounds, their preparation and use
ES2295200T3 (es) * 2000-08-23 2008-04-16 Eli Lilly And Company Derivados de acido oxazolil-arilpropionico y su uso como agonistas de ppar.
KR100659679B1 (ko) 2000-09-01 2006-12-21 에자이 가부시키가이샤 1-벤질-4-[(5,6-디메톡시-2-플루오로-1-인다논)-2-일]메틸피페리딘
JPWO2002080899A1 (ja) * 2001-03-30 2005-01-06 エーザイ株式会社 消化器疾患治療剤
TWI311133B (en) * 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
NZ529351A (en) * 2001-06-07 2006-01-27 Lilly Co Eli Modulators of peroxisome proliferator activated receptors

Similar Documents

Publication Publication Date Title
US20050020684A1 (en) Modulators of peroxisome proliferator activated receptors
JP2005509590A6 (ja) ペルオキシソーム増殖因子活性化受容体の調節物質
US7649110B2 (en) Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
JP2006500384A5 (enExample)
JP2004518702A5 (enExample)
JP2004513076A5 (enExample)
US7176204B2 (en) Substituted carboxylic acid derivatives
US20070037812A1 (en) Phenoxyether derivatives as ppar modulators
JP2005529965A (ja) ｈＰＰＡＲ活性化物質としてのフェニルオキシアルカン酸誘導体
JP2007508382A5 (enExample)
JP4819801B2 (ja) ヘキセン酸誘導体、その調製方法、それらを含む医薬組成物およびその治療用途
AU2003241579B9 (en) Amide linker peroxisome proliferator activated receptor modulators
JP2009514964A (ja) Ｐｐａｒモジュレーターとしての化合物および組成物
JP2004532267A5 (enExample)
JP2007536291A (ja) ブタン酸誘導体、その調製方法、それらを含む医薬組成物およびその治療用途
US7361783B2 (en) (2S)-2-ethylphenylpropionic acid derivative
US7491747B2 (en) Butyric acid derivatives
US7321056B2 (en) Selective peroxisome proliferator activated receptor modulators
EP1836150B1 (en) Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
KR20090077091A (ko) 신규 퍼옥시좀 증식자-활성화 수용체 효능제인 화합물 및그 제조방법
US7544687B2 (en) Substituted α-piperazinyl phenylpropionic acid derivatives as hPPAR α and/or hPPAR γ agonists
AU2002312147A1 (en) Modulators of peroxisome proliferator activated receptors
ES2352071T3 (es) Derivados de tirosina sustituidos con n-fenilacroloilo como agonostas de hppar alfa y de hppar gama.
JP2006527215A5 (enExample)
TH67533A (th) Pparอัลฟา และ pparแกมมา แอกโกนิสท์ชนิดใหม่